CME GROUP INC's gross profit margin for the fourth quarter of its fiscal year 2014 is essentially unchanged when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. CME GROUP INC has very weak liquidity. Currently, the Quick Ratio is 0.04 which clearly shows a lack of ability to cover short-term cash needs. The company's liquidity decreased from the same period a year ago, despite already having very weak liquidity to begin with. This would indicate deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has remained virtually unchanged only decreasing by 1.09% from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY14||Q4 FY13|
|Net Sales ($mil)||851.2||697.0|
|Net Income ($mil)||306.5||193.1|
|Balance Sheet||Q4 FY14||Q4 FY13|
|Cash & Equiv. ($mil)||1477.8||2578.1|
|Total Assets ($mil)||72241.5||54277.8|
|Total Debt ($mil)||2107.9||2857.1|
|Profitability||Q4 FY14||Q4 FY13|
|Gross Profit Margin||63.44||60.77|
|Return on Assets||1.56||1.79|
|Return on Equity||5.38||4.61|
|Debt||Q4 FY14||Q4 FY13|
|Share Data||Q4 FY14||Q4 FY13|
|Shares outstanding (mil)||334.99||333.86|
|Div / share||2.47||3.05|
|Book value / share||62.46||63.37|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||1532213.0||1592810.0|
BUY. This stock's P/E ratio indicates a significant discount compared to an average of 11072.53 for the Diversified Financial Services industry and a premium compared to the S&P 500 average of 19.92. To use another comparison, its price-to-book ratio of 1.54 indicates a discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 950.70. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, CME GROUP INC proves to trade at a discount to investment alternatives within the industry.
|CME 28.66||Peers 11072.53||CME NA||Peers 7610.96|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
CME is trading at a significant discount to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|CME 22.33||Peers 12.82||CME 1.64||Peers 0.25|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
CME is trading at a significant premium to its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
CME trades at a significant premium to its peers.
|CME 1.54||Peers 950.70||CME 14.33||Peers 11.45|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CME is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
CME is expected to have an earnings growth rate that significantly exceeds its peers.
|CME 10.22||Peers 1144.34||CME 5.78||Peers 12.62|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CME is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
CME significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV